GlassScriptPhysician profile
Amaresh Vydyanathan
NPI 1336319094
$6,396.46
in general payments reported to CMS, 2019-2025
17 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $160 · 2021: $804 · 2022: $887 · 2023: $826 · 2024: $848 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760 · Travel and Lodging: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.96 |
| Travel and Lodging | $682.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,204.44 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $847.86 | 2021-2024 | Senza |
| Edwards Lifesciences Corporation | $700.00 | 2019-2021 | |
| Medtronic, INC. | $552.16 | 2021-2025 | Intellis Adaptivestim, Nellcor |
| Spr Therapeutics, INC | $218.12 | 2023-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $211.37 | 2024-2025 | |
| Abbvie INC. | $126.63 | 2023-2025 | Ubrelvy, Botox |
| Globus Medical, INC. | $116.28 | 2025 | Senza |
| Cumberland Pharmaceuticals, INC. | $102.34 | 2021-2022 | |
| Heron Therapeutics, INC. | $89.85 | 2021 | |
| Trice Medical, INC. | $70.13 | 2024 | |
| Averitas Pharma INC. | $46.70 | 2025 | Qutenza |
| Avanos Medical | $41.89 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $20.99 | 2021 | |
| Medtronic USA, INC. | $16.89 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $16.28 | 2025 | Evoke |
| Stimwave Technologies Incorporated | $14.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amaresh Vydyanathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.